Clinical Trial Update: Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of empagliflozin or semaglutide in overweight/obese adults with type 1 diabetes; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (Jardiance) (empagliflozin)
• Semaglutide (Ozempic) (semaglutide)

Snippet

Sponsor: Mostafa Bahaa | Conditions: Diabetes | Phase 2 | Status: RECRUITING